“Advancing Cardiovascular Care and Innovations in Stent Technologies”
- The growing prevalence of cardiovascular diseases across Asia-Pacific, particularly coronary artery disease, is significantly driving the demand for advanced cardiac stents, including drug-eluting stents (DES), bare-metal stents (BMS), and bioresorbable scaffolds.
- Increasing investments in minimally invasive cardiac procedures are boosting the adoption of next-generation stents, which offer enhanced biocompatibility, reduced restenosis rates, and improved long-term patient outcomes.
- For instance, medical device companies in China and India are developing drug-eluting stents with biodegradable polymers to address post-procedural complications and support vessel healing.
- Rising use of cardiac stents in both clinical and outpatient settings is supported by regulatory harmonization, robust reimbursement frameworks, and clinical data validation across Asia-Pacifica markets.
- Technological advancements, including stent coating innovations, imaging-guided implantation, and patient-specific stent design, are complementing—not replacing—traditional stenting methods, ensuring performance reliability in both routine and complex cases growth.
